Perimeter
Perimeter Systems, Inc. is a Boston-based biosecurity infrastructure company that builds the Biothreat Radar platform for government agencies, defense organizations, and public health authorities to detect, characterize, and respond to biological threats across a global surveillance network.
- Company typePrivate
- Founded2019
- HeadquartersBoston, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Perimeter does
Perimeter Systems, Inc. is a Boston-based biosecurity infrastructure company that builds the Biothreat Radar platform for government agencies, defense organizations, healthcare systems, and public health authorities. The platform integrates four core modules—Detect, Characterize, Respond, and Forecast—through a global network of biosurveillance nodes spanning airports, hospitals, municipal wastewater systems, and critical infrastructure across the United States, Africa, the Middle East, Ukraine, and Georgia. The Traveler-Based Genomic Surveillance (TGS) program operates across 8 international airports covering 135+ countries of origin, having collected samples from over one million international traveler volunteers and 2,600+ wastewater samples since 2021. The company's go-to-market is exclusively direct enterprise and government sales, with quote-based contract pricing and no self-serve or consumer motion.
The company's technical foundation rests on proprietary capabilities including ENDAR (Engineered Nucleotide Detection and Ranking), a first-of-its-kind analysis toolkit developed under the IARPA FELIX program that distinguishes genetic engineering from natural evolution or sequencing noise at sensitivity down to 50 base pairs and up to 10x back-dilution. ENDAR was ranked first among dry lab performers in the FELIX program and validated through four test and evaluation exercises with US National Laboratories. The Characterize module combines computational biology with frontier AI to assess pathogen risk, while the Forecast module provides custom risk models with off-the-shelf models available for measles, avian influenza, Marburg virus, and foot-and-mouth disease. Demonstrated outcomes include identifying H3N2 subclade K seven days before public repository appearance in August 2025, developing a pan-clade Mpox PCR assay within three weeks when standard diagnostics failed, and detecting vancomycin-resistant Enterococci a full week before clinical identification at a military treatment facility.
Perimeter generates revenue through subscription-based and managed-services contracts with government and institutional customers for biosurveillance and biothreat intelligence services, with pricing negotiated directly rather than publicly disclosed. In April 2026, the company acquired substantially all of Ginkgo Bioworks' Biosecurity business in exchange for a minority equity stake and closed a $60M financing round led by Kanders & Company with participation from Four Cities Capital, Goldcrest Capital, Safe AI Fund, and SCS Financial. Customers referenced in source materials include the California Department of Public Health, Defense Centers for Public Health-Aberdeen, the Association of Public Health Laboratories (APHL), and U.S. Military Treatment Facilities.
Perimeter firmographics
Firmographics- Name
- Perimeter
- Legal name
- Perimeter Systems, Inc.
- Website
- https://perimeter.bio
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Perimeter Systems, Inc. is a Boston-based biosecurity infrastructure company that builds the Biothreat Radar platform for government agencies, defense organizations, and public health authorities to detect, characterize, and respond to biological threats across a global surveillance network.
- Ownership category
- akta.pro rank
Perimeter industry classification
Industry- Product category
- Biosecurity Infrastructure
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Biothreat/Biocontainment & Select Agent Public Health Laboratories (HLAJAIAL)
- akta.pro secondary industry
- Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)
Keywords
Where Perimeter is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Perimeter business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Biosecurity Infrastructure Services: Subscription or contract-based biosurveillance and biothreat intelligence services deployed across airports, hospitals, military installations, and critical infrastructure. Revenue derived from government and institutional contracts for threat detection, characterization, and response guidance.
- Custom Monitoring Programs: Tailored biosurveillance programs for specific operational environments (e.g., military treatment facilities, conflict zones). Revenue from specialized deployments and ongoing monitoring services.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Perimeter product offering
Product offeringCore offering
Perimeter operates a Biothreat Radar platform that combines distributed physical sampling (airports, hospitals, wastewater, critical infrastructure), metagenomic sequencing, and AI-enabled computational biology to forecast, detect, characterize, and respond to biological threats. It delivers always-on biosurveillance, genetic engineering detection through the proprietary ENDAR toolkit, predictive risk modeling, and tailored intelligence products for government, defense, healthcare, and public health customers.
Product overview
Perimeter offers a unified biosecurity platform called the Biothreat Radar, which integrates four core modules—Detect, Characterize, Respond, and Forecast—to provide comprehensive biothreat intelligence. Detect enables layered collection through global biosurveillance nodes; Characterize combines computational biology with AI for risk assessment and genetic engineering detection; Respond synthesizes intelligence for decisive action; and Forecast provides predictive risk modeling. The platform is enhanced by specialized capabilities including ENDAR for engineered nucleotide detection and the TGS Program for airport-based genomic surveillance. A pan-clade wastewater PCR assay developed for Mpox is also available as an off-the-shelf kit.
Differentiator
Problem solved
Functional benefit
Brands
- ENDAR: Engineered Nucleotide Detection and Ranking system - a first-of-its-kind analysis toolkit that distinguishes genetic engineering from natural evolution or sequencing noise, developed in collaboration with IARPA under the FELIX program.
Products and services
- Biothreat Radar Platform Always-on biosurveillance platform that forecasts and detects biological threats as they emerge, characterizes risk for specific operational contexts, and guides intelligent response for government agencies, defense organizations, healthcare systems, and public health authorities.
- TGS (Traveler-Based Genomic Surveillance) Program Traveler-based genomic surveillance network operating across 8 international airports covering 135+ countries of origin, with over one million international traveler volunteers and 2,600+ wastewater samples collected since 2021 to detect emerging health threats and track new variants.
- ENDAR (Engineered Nucleotide Detection and Ranking) Proprietary analysis toolkit that distinguishes genetic engineering from natural evolution or sequencing noise, detecting genetic manipulations as small as 50 base pairs in viruses, bacteria, fungi, and plants, and detecting engineered material at up to 10x back-dilution into non-engineered parental strains.
- Pan-Clade Wastewater PCR Assay Wastewater PCR assay kit for detecting Mpox Clade Ib, developed within approximately 3 weeks, validated by Defense Centers for Public Health-Aberdeen, and available as an off-the-shelf product through the Association of Public Health Laboratories (APHL).
Quantifiable outcome
- Identified novel H3N2 subclade K seven days before public repository appearance, enabling proactive public health response
- +3 more outcomes
Companies that use Perimeter
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Perimeter technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature5 records
Perimeter partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- IARPA (Intelligence Advanced Research Projects Activity)coreCollaboration under the FELIX (Finding Engineering-Linked Indicators) program to develop ENDAR - a first-of-its-kind analysis toolkit for distinguishing genetic engineering from natural evolution. ENDAR ranked first among dry lab performers in the FELIX program and was validated through 4 T&E exercises with US National Labs. This partnership established Perimeter's technical leadership in genetic engineering detection.
- Association of Public Health Laboratories (APHL)coreDistributes Perimeter's pan-clade wastewater PCR assay kit for Mpox detection, making the validated assay available as an off-the-shelf product to public health laboratories nationwide. Kit also validated by Defense Centers for Public Health-Aberdeen.
- Ginkgo BioworksminorPerimeter acquired Ginkgo Bioworks' Biosecurity business unit on April 3, 2026, receiving substantially all Biosecurity operations in exchange for a minority equity stake in Perimeter. This acquisition expanded Perimeter's biosecurity infrastructure capabilities.
Scale indicators10 records
Recent moves6 records
Expansion highlights7 records
Perimeter competitors and assessment
Company assessmentBroad incumbents
- Parsons Corporation: Government services and defense contractor with biosurveillance and CBRN (chemical, biological, radiological, nuclear) defense capabilities. Competes for federal biosecurity programs alongside Perimeter.
- CACI International: Federal IT and engineering services provider with biosurveillance and threat intelligence offerings for defense and intelligence community customers. Overlaps with Perimeter's government-facing biosecurity infrastructure.
- Leidos: Large federal contractor with health and biodefense capabilities including biosurveillance and threat characterization. Competes with Perimeter for defense and public health agency contracts, though as part of a much broader portfolio.
- QIAGEN: Molecular diagnostics and sample preparation technologies company serving public health, biosecurity, and research customers. Comparable to Perimeter on the laboratory assay and pathogen detection tooling layer.
- bioMérieux (BioFire Diagnostics): Global in vitro diagnostics company with strong pathogen detection and syndromic testing panels (FilmArray/BioFire). Comparable to Perimeter on the infectious disease detection side, particularly for hospital and public health lab customers.
- Battelle Memorial Institute: Nonprofit applied science organization with deep biodefense research and biosurveillance capabilities for government customers. Directly comparable on biothreat detection R&D and federal contract work.
- Booz Allen Hamilton: Major government services contractor with a biosurveillance and biodefense practice (notably via its acquisition of Metabiota). Competes for the same federal biosurveillance contracts that Perimeter serves, but as a much larger, diversified prime contractor.
Direct peers
- Ginkgo Bioworks: Synthetic biology platform company that spun/contributed its Biosecurity business to Perimeter in April 2026 in exchange for a minority equity stake. Closely tied commercially and strategically, with overlapping biosecurity infrastructure heritage.
- Metabiota (a Booz Allen Hamilton company): Direct biosurveillance and pandemic risk analytics peer now operating within Booz Allen Hamilton. Offers epidemic risk monitoring and early warning capabilities very similar to Perimeter's Biothreat Radar, targeting government, insurance, and public health customers.
Emerging players
- Cepheid (Danaher): Molecular diagnostics company (part of Danaher) with rapid PCR testing systems used in public health, hospital, and biodefense settings. Comparable on the pathogen diagnostic technology stack that Perimeter integrates and extends.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Perimeter social profiles
Digital presencePerimeter financial estimates
Financial estimateRevenue estimate
Valuation estimate
Perimeter leadership team
Management profileNumber of profiles
Perimeter funding detail
Funding detailFunding overview
Funding rounds1 record
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Perimeter M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Perimeter
What does Perimeter do?
Perimeter operates a Biothreat Radar platform that combines distributed physical sampling (airports, hospitals, wastewater, critical infrastructure), metagenomic sequencing, and AI-enabled computational biology to forecast, detect, characterize, and respond to biological threats. It delivers always-on biosurveillance, genetic engineering detection through the proprietary ENDAR toolkit, predictive risk modeling, and tailored intelligence products for government, defense, healthcare, and public health customers.
Is Perimeter a public or private company?
Perimeter is a private company. It is classified as venture growth investor backed and is currently operating.
When was Perimeter founded?
Perimeter was founded in 2019. It employs 51 to 100 people.
Where is Perimeter based?
Perimeter is headquartered in Boston, United States, in the North America region.
How does Perimeter make money?
Two revenue lines are on record. Biosecurity Infrastructure Services are the primary driver. The others are custom Monitoring Programs.
Who are Perimeter's main competitors?
Broad incumbents on record are Parsons Corporation, CACI International, Leidos, QIAGEN, bioMérieux (BioFire Diagnostics), Battelle Memorial Institute and Booz Allen Hamilton. Direct peers are Ginkgo Bioworks and Metabiota (a Booz Allen Hamilton company). Cepheid (Danaher) is listed as an emerging player.
Does Perimeter have an API?
No public API is recorded for Perimeter.
What industry is Perimeter in?
Perimeter's product category is Biosecurity Infrastructure. Its primary akta.pro industry code is HLAJAIAL, Biothreat/Biocontainment & Select Agent Public Health Laboratories, with a secondary code of HLAGAEAF, Microbiology & Infectious Disease Testing (Trial Support). Its NAICS code is 541714 and its SIC code is 8731.